221 related articles for article (PubMed ID: 34984651)
1. Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis.
Tallon C; Sharma A; Zhang Z; Thomas AG; Ng J; Zhu X; Donoghue A; Schulte M; Joe TR; Kambhampati SP; Sharma R; Liaw K; Kannan S; Kannan RM; Slusher BS
Neurotherapeutics; 2022 Jan; 19(1):274-288. PubMed ID: 34984651
[TBL] [Abstract][Full Text] [Related]
2. Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis.
Hollinger KR; Sharma A; Tallon C; Lovell L; Thomas AG; Zhu X; Wiseman R; Wu Y; Kambhampati SP; Liaw K; Sharma R; Rojas C; Rais R; Kannan S; Kannan RM; Slusher BS
Nanotheranostics; 2022; 6(2):126-142. PubMed ID: 34976589
[TBL] [Abstract][Full Text] [Related]
3. Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the
Martineau É; Arbour D; Vallée J; Robitaille R
J Neurosci; 2020 Sep; 40(40):7759-7777. PubMed ID: 32859714
[TBL] [Abstract][Full Text] [Related]
4. Muscle fiber-type specific terminal Schwann cell pathology leads to sprouting deficits following partial denervation in SOD1
Harrison JM; Rafuse VF
Neurobiol Dis; 2020 Nov; 145():105052. PubMed ID: 32827689
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
6. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury.
Arteaga Cabeza O; Zhang Z; Smith Khoury E; Sheldon RA; Sharma A; Zhang F; Slusher BS; Kannan RM; Kannan S; Ferriero DM
Neurobiol Dis; 2021 Jan; 148():105201. PubMed ID: 33271328
[TBL] [Abstract][Full Text] [Related]
8. Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP-43 overexpression mouse model of amyotrophic lateral sclerosis.
Alhindi A; Shand M; Smith HL; Leite AS; Huang YT; van der Hoorn D; Ridgway Z; Faller KME; Jones RA; Gillingwater TH; Chaytow H
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12925. PubMed ID: 37465879
[TBL] [Abstract][Full Text] [Related]
9. Assessment of metal concentrations in the SOD1
Enge TG; Ecroyd H; Jolley DF; Yerbury JJ; Kalmar B; Dosseto A
Mol Cell Neurosci; 2018 Apr; 88():319-329. PubMed ID: 29524628
[TBL] [Abstract][Full Text] [Related]
10. Adipose-derived stem cell conditioned medium impacts asymptomatic peripheral neuromuscular denervation in the mutant superoxide dismutase (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
Walker CL; Meadows RM; Merfeld-Clauss S; Du Y; March KL; Jones KJ
Restor Neurol Neurosci; 2018; 36(5):621-627. PubMed ID: 30010155
[TBL] [Abstract][Full Text] [Related]
11. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
12. Argonaute 2 is lost from neuromuscular junctions affected with amyotrophic lateral sclerosis in SOD1
Shapiro D; Massopust R; Taetzsch T; Valdez G
Sci Rep; 2022 Mar; 12(1):4630. PubMed ID: 35301367
[TBL] [Abstract][Full Text] [Related]
13. Muscle Expression of SOD1
Dobrowolny G; Martini M; Scicchitano BM; Romanello V; Boncompagni S; Nicoletti C; Pietrangelo L; De Panfilis S; Catizone A; Bouchè M; Sandri M; Rudolf R; Protasi F; Musarò A
Antioxid Redox Signal; 2018 Apr; 28(12):1105-1119. PubMed ID: 28931313
[TBL] [Abstract][Full Text] [Related]
14. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
[TBL] [Abstract][Full Text] [Related]
16. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis.
Bros-Facer V; Krull D; Taylor A; Dick JR; Bates SA; Cleveland MS; Prinjha RK; Greensmith L
Hum Mol Genet; 2014 Aug; 23(16):4187-200. PubMed ID: 24667415
[TBL] [Abstract][Full Text] [Related]
17. Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset.
Rocha MC; Pousinha PA; Correia AM; Sebastião AM; Ribeiro JA
PLoS One; 2013; 8(9):e73846. PubMed ID: 24040091
[TBL] [Abstract][Full Text] [Related]
18. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex.
Thomsen GM; Gowing G; Latter J; Chen M; Vit JP; Staggenborg K; Avalos P; Alkaslasi M; Ferraiuolo L; Likhite S; Kaspar BK; Svendsen CN
J Neurosci; 2014 Nov; 34(47):15587-600. PubMed ID: 25411487
[TBL] [Abstract][Full Text] [Related]
19. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
20. Expression of ALS-linked SOD1 Mutation in Motoneurons or Myotubes Induces Differential Effects on Neuromuscular Function In vitro.
Benlefki S; Sanchez-Vicente A; Milla V; Lucas O; Soulard C; Younes R; Gergely C; Bowerman M; Raoul C; Scamps F; Hilaire C
Neuroscience; 2020 May; 435():33-43. PubMed ID: 32234507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
